Search

Boehringer Ingelheim announces 2018 BVDzero Case Awards

Boehringer Ingelheim announces 2018 BVDzero Case Awards Boehringer Ingelheim will provide a total prize of €15,000 for the top 10 clinical cases entered Applications can be submitted on www.bvdzero.com

New biomass power plant Ingelheim

Boehringer Ingelheim produces its own green energy

EASi-HF™ Phase III trial in patients with HFpEF

Boehringer Ingelheim's Sandy Sommer on the global urgency for innovative heart failure care and the significance of the clinical trial for patients with HFpEF worldwide.

EASi-KIDNEY™ Phase III trial for people with CKD

Boehringer Ingelheim's Sandy Sommer on how treatment innovations in CKD can also improve care for connected conditions, including heart failure.

Rethinking mental health care

Outdated perceptions and practices fuelling mental health crisis, new Economist Impact study reveals

Partnership to Develop Urea Cycle Disorders Therapy

Boehringer Ingelheim Partners with Thoeris to Investigate a Novel Approach to Treat Urea Cycle Disorders

LastMile increases access to veterinary care in Africa

Boehringer Ingelheim’s LastMile initiative reaches over 40,000 smallholder farmers in Sub-Saharan Africa increasing access to veterinary medicine

Largest European development center for biotechnology

Boehringer Ingelheim inaugurates largest European development center for biotechnology

Niha Agarwalla

My career challenge at Boehringer Ingelheim by Niha Agarwalla. Read it now!

Development Biotechnology sustainable cell culture

Boehringer Ingelheim refines its bioprocess technology operations in Animal Health with greater focus on environmental sustainability to reduce footprint

Sabine Reinig

For Sabine, who leads Boehringer Ingelheim’s global people strategy, continuous development is the essence of a successful career. Clear aspirations and openness to new opportunities are her key ingredients.

bix_facilitates_global_partnerships

BI X focuses on partnerships to speed up the development of digital healthcare solutions

Boehringer Ingelheim supports collaboration and knowledge sharing in the livestock industry

Boehringer Ingelheim demonstrates its commitment to farm animal well-being by organising its 11th Expert Forum on Farm Animal Well-Being

PREVEXXION® RN: Marek’s disease vaccine available in EU UK

Boehringer Ingelheim is pleased to announce the launch of the next generation of Marek’s disease vaccines is now available in the EU.

digital_leader_award_2020

Boehringer Ingelheim wins first place in the "STRATEGY" category of the Digital Leader Award

Boehringer Ingelheim partners with GNA Biosolutions

Boehringer Ingelheim partners with GNA Biosolutions to develop African swine fever diagnostic test.

2020 European PRRS Research Award sponsorship

2020 European PRRS Research Award: Boehringer Ingelheim calls for submissions

What we do

Boehringer Ingelheim is a multinational corporation with divisions dedicated to Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.

Boehringer Ingelheim Social Engagements

Boehringer Ingelheim Social Engagements Contributes to company commitment to impact 50 million people in vulnerable communities by 2030 through supporting social entrepreneurs and innovative solutions

inauguration_biopharmaceutical_production_facility_vienna

The state-of-the-art biopharmaceutical production facility in Vienna is the single largest investment in the company's history.

Boehringer receives SBTi validation for CO2 reduction targets

Boehringer Ingelheim receives SBTi validation for CO2 reduction targets

Data science, agile working, UX design: our evolving IT careers

Meet our IT colleagues working in the fields of user experience, data science and agile development

Phase 1 start of treatment for Geographic Atrophy patients

Boehringer initiates Phase 1 evaluation of BI 771716 a treatment for preserving vision of people living with geographic atrophy (GA)

Breakthrough in Artificial Intelligence ChatGPT

Is ChatGPT the AI revolution we were waiting for or only media hype? Experts from Boehringer Ingelheim take a close look.

Second cancer immunotherapy partnership with 3T Bio

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers